NO20021949D0 - Nye hormonpreparater og anvendelse av dem - Google Patents

Nye hormonpreparater og anvendelse av dem

Info

Publication number
NO20021949D0
NO20021949D0 NO20021949A NO20021949A NO20021949D0 NO 20021949 D0 NO20021949 D0 NO 20021949D0 NO 20021949 A NO20021949 A NO 20021949A NO 20021949 A NO20021949 A NO 20021949A NO 20021949 D0 NO20021949 D0 NO 20021949D0
Authority
NO
Norway
Prior art keywords
hormone preparations
new hormone
esters
menopausal women
new
Prior art date
Application number
NO20021949A
Other languages
English (en)
Other versions
NO327973B1 (no
NO20021949L (no
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO20021949D0 publication Critical patent/NO20021949D0/no
Publication of NO20021949L publication Critical patent/NO20021949L/no
Publication of NO327973B1 publication Critical patent/NO327973B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
NO20021949A 1999-10-25 2002-04-25 Anvendelse av en kombinert ostroprogestativ forbindelse for fremstilling av et medikament for korreksjon av ostrogenforstyrrelser hos kvinner samt forebyggelse av osteoporose og kardiovaskulaere sykdommer hos kvinner i overgangsalder NO327973B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002588 WO2001030356A1 (fr) 1999-10-25 1999-10-25 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
PCT/FR2000/002939 WO2001030357A1 (fr) 1999-10-25 2000-10-24 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Publications (3)

Publication Number Publication Date
NO20021949D0 true NO20021949D0 (no) 2002-04-25
NO20021949L NO20021949L (no) 2002-04-25
NO327973B1 NO327973B1 (no) 2009-11-02

Family

ID=9542727

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021949A NO327973B1 (no) 1999-10-25 2002-04-25 Anvendelse av en kombinert ostroprogestativ forbindelse for fremstilling av et medikament for korreksjon av ostrogenforstyrrelser hos kvinner samt forebyggelse av osteoporose og kardiovaskulaere sykdommer hos kvinner i overgangsalder

Country Status (27)

Country Link
US (2) US8168619B1 (no)
EP (1) EP1227814B1 (no)
JP (1) JP5036943B2 (no)
KR (1) KR100623788B1 (no)
CN (1) CN100553637C (no)
AP (1) AP1625A (no)
AT (1) ATE286400T1 (no)
AU (1) AU777704B2 (no)
BR (1) BRPI0014979B8 (no)
CA (1) CA2389025C (no)
CZ (1) CZ303248B6 (no)
DE (1) DE60017281T2 (no)
DK (1) DK1227814T3 (no)
ES (1) ES2235967T3 (no)
HK (1) HK1050472B (no)
HU (1) HU229382B1 (no)
IL (2) IL148953A0 (no)
MX (1) MXPA02004084A (no)
NO (1) NO327973B1 (no)
NZ (1) NZ518145A (no)
OA (1) OA12072A (no)
PL (1) PL199848B1 (no)
PT (1) PT1227814E (no)
RU (1) RU2261106C2 (no)
SI (1) SI1227814T1 (no)
WO (2) WO2001030356A1 (no)
ZA (1) ZA200203398B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
ATE350041T1 (de) 2001-05-18 2007-01-15 Pantarhei Bioscience Bv Pharmaceutishe zusammensetzung für die hormonersatztherapie
EP1390041B1 (en) 2001-05-23 2009-11-25 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
DE60223795T2 (de) 2001-05-23 2008-11-27 Pantarhei Bioscience B.V. Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption
DE60216630T2 (de) * 2001-11-15 2007-09-20 Pantarhei Bioscience B.V. Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
SI1511496T1 (sl) 2002-06-11 2007-04-30 Pantarhei Bioscience Bv Metoda zdravljenja ali prevencije imunsko mediiranih motenj in farmacevtska formulacija za njeno uporabo
AU2003274941A1 (en) 2002-06-11 2003-12-22 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
TW200404548A (en) * 2002-06-25 2004-04-01 Wyeth Corp Pharmaceutical composition containing cyclothiocarbamate derivatives in treatment of hormone-related conditions
CA2492287C (en) 2002-07-12 2011-12-13 Pantarhei Bioscience B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
AU2003274823A1 (en) 2002-10-23 2004-05-13 Pantarhei Bioscience B.V. Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
CA2674325A1 (en) 2007-01-08 2008-07-17 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
CN107007611B (zh) * 2017-06-02 2020-04-14 上海市计划生育科学研究所 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
DE3603644A1 (de) 1986-02-06 1987-08-13 Metabowerke Kg Spannfutter zum einspannen von bohrern oder schlagbohrern
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
DE3888269T2 (de) 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
FR2695826B1 (fr) 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE69629702T2 (de) 1995-08-01 2004-06-17 Isis Pharmaceuticals, Inc., Carlsbad Liposomale oligonukleotidzusammensetzungen
US5888543A (en) 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
DE60218881T2 (de) * 2001-11-15 2007-12-20 Pantarhei Bioscience B.V. Verfahren zur vorbeugung oder behandlung von benignen gynäkologischen störungen
PE20081895A1 (es) 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Also Published As

Publication number Publication date
JP5036943B2 (ja) 2012-09-26
US9084796B2 (en) 2015-07-21
AP1625A (en) 2006-07-04
AU1032601A (en) 2001-05-08
BR0014979A (pt) 2002-11-26
NZ518145A (en) 2005-01-28
IL148953A0 (en) 2002-11-10
BRPI0014979B8 (pt) 2021-05-25
DE60017281D1 (de) 2005-02-10
CN1382053A (zh) 2002-11-27
RU2261106C2 (ru) 2005-09-27
RU2002113652A (ru) 2004-03-27
NO327973B1 (no) 2009-11-02
DK1227814T3 (da) 2005-04-11
CA2389025C (fr) 2009-12-08
CN100553637C (zh) 2009-10-28
JP2003515531A (ja) 2003-05-07
DE60017281T2 (de) 2005-12-08
HK1050472A1 (en) 2003-06-27
CZ20021427A3 (cs) 2002-08-14
HUP0203721A2 (hu) 2003-03-28
HUP0203721A3 (en) 2003-07-28
MXPA02004084A (es) 2003-08-20
ES2235967T3 (es) 2005-07-16
HU229382B1 (hu) 2013-11-28
AU777704B2 (en) 2004-10-28
SI1227814T1 (en) 2005-06-30
KR20020057979A (ko) 2002-07-12
US8168619B1 (en) 2012-05-01
BRPI0014979B1 (pt) 2016-08-02
WO2001030356A1 (fr) 2001-05-03
PT1227814E (pt) 2005-05-31
IL148953A (en) 2007-06-03
ATE286400T1 (de) 2005-01-15
PL199848B1 (pl) 2008-11-28
CZ303248B6 (cs) 2012-06-20
AP2002002475A0 (en) 2002-06-30
CA2389025A1 (fr) 2001-05-03
KR100623788B1 (ko) 2006-09-18
NO20021949L (no) 2002-04-25
PL356847A1 (en) 2004-07-12
WO2001030357A1 (fr) 2001-05-03
EP1227814B1 (fr) 2005-01-05
HK1050472B (zh) 2005-07-08
OA12072A (fr) 2006-05-04
US20130172300A1 (en) 2013-07-04
ZA200203398B (en) 2003-12-03
EP1227814A1 (fr) 2002-08-07

Similar Documents

Publication Publication Date Title
NO20021949D0 (no) Nye hormonpreparater og anvendelse av dem
NO975586D0 (no) Transdermal innretning og fremgangsmåte for administrering av 17-deacetyl norgestimat alene eller i kombinasjon med et östrogen
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
KR960700727A (ko) 호르몬 대체 치료(hormone replacement therapy)
HRP20020837B1 (en) Hormone replacement therapy
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
EP0402950A3 (en) Treatment of postmenopausal disorders
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
CA2356747A1 (en) Triphasic oral contraceptive
AU3263197A (en) Pharmaceutical composition for oral delivery
HUP9904344A2 (hu) Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit
AR033042A1 (es) Terapia de reemplazo hormonal
HUP9900612A2 (hu) Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra
NZ333862A (en) Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
DE69724796D1 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
AR039477A1 (es) Terapia de reemplazo hormonal
DE59404903D1 (de) Oral estrogen wirksame ester des 14 alpha,15 alpha-methylen-estradiols
UA30722A (uk) Спосіб профілактики гнійно-септичних ускладнень у породіль
MD1715F1 (en) Method of prophylaxis and treatment of the precocious hypogalactia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees